Results 211 to 220 of about 21,326 (236)
Some of the next articles are maybe not open access.

Related searches:

Oncostatin M

Progress in Growth Factor Research, 1992
Oncostatin M (OSM) was initially identified as a polypeptide cytokine which inhibited the in vitro growth of cells from melanoma and other solid tumors. OSM shows significant similarities in primary amino acid sequence and predicted secondary structure to leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), granulocyte colony ...
A G, Bruce, P S, Linsley, T M, Rose
openaire   +2 more sources

Oncostatin M: A mysterious cytokine in cancers

International Immunopharmacology, 2021
Oncostatin M (OSM), as a member of the Interleukin-6 family cytokines, plays a significant role in inflammation, autoimmunity, and cancers. It is mainly secreted by T lymphocytes, neutrophils, and macrophages and was initially introduced as anti-cancer agent. However, in some cases, it promotes cancer progression. Overexpression of OSM and OSM receptor
Ali, Masjedi   +7 more
openaire   +2 more sources

Oncostatin M (OSM)

1995
Abstract OSM is a secreted glycoprotein monomer with a M, of 28 000 Da (Zarling et al. 1986). Nucleotide sequence analysis of OSM cDNA and genomic clones (human sequence-GenBank accession numbers M27286, M27287, M27288, M26966; Simian sequence-unpublished), determined that OSM was initially expressed as a 252-amino-acid precursor ...
T M Rose, A G Bruce
openaire   +1 more source

Regulation of Inflammatory Responses by Oncostatin M

The Journal of Immunology, 1999
AbstractOncostatin M (OM) is a pleiotropic cytokine produced late in the activation cycle of T cells and macrophages. In vitro it shares properties with related proteins of the IL-6 family of cytokines; however, its in vivo properties and physiological function are as yet ill defined.
P M, Wallace   +6 more
openaire   +2 more sources

Oncostatin M stimulates proliferation in B9 hybridoma cells: Potential role of oncostatin M in plasmacytoma development

Cytokine, 1994
Oncostatin M was found to stimulate the IL-6-addicted hybridoma line B9. Leukaemia inhibitory factor did not stimulate proliferation of this line. Both of these factors bind to the gp130 of the IL-6 receptor. In another cell line that is stimulated by LIF (DA.1), neither IL-6 nor oncostatin M stimulated proliferation.
B E, Barton   +3 more
openaire   +2 more sources

Upregulation of Oncostatin M in Allergic Rhinitis

The Laryngoscope, 2005
AbstractObjectives: Oncostatin M is a multifunctional cytokine belonging to the interleukin‐6 family of cytokines. It has been implicated as an important modulator of lower airway remodeling in the setting of asthma. However, there have been few studies regarding a similar role for the upper airway epithelium in the setting of allergic rhinitis.
Hee Joon, Kang   +6 more
openaire   +2 more sources

Oncostatin M in the anti-inflammatory response

Annals of the Rheumatic Diseases, 2001
Oncostatin M (OM) is a pleiotropic cytokine of the interleukin 6 family, whose in vivo properties and physiological function remain in dispute and poorly defined. These in vivo studies strongly suggest that OM is anabolic, promoting wound healing and bone formation, and anti-inflammatory.
A F, Wahl, P M, Wallace
openaire   +2 more sources

Oncostatin M: Signal transduction and biological activity

Life Sciences, 1999
Oncostatin M (OSM) is a multifunctional cytokine produced by activated T lymphocytes and monocytes that is structurally and functionally related to the subfamily of cytokines known as the IL-6-type cytokine family. OSM shares properties with all members of this family of cytokines, but is most closely related structurally and functionally to LIE OSM ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy